Ethicann Pharmaceuticals
Bethesda · Founded 2018
About Ethicann Pharmaceuticals
Ethicann Pharmaceuticals uses pharmaceutical-grade botanically sourced cannabinoid oils to formulate ethical drugs. It targets several different large-market diseases for its THC+CBD ethical pharmaceutical drugs; namely and in order of launch, spasticity from multiple sclerosis, adult focal epilepsy, chemotherapy-induced nausea and vomiting (CINV), and chronic pain from cancer.
Company Facts
- Founded: 2018
- Legal name: Ethicann Pharmaceuticals Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Convertible Note (Jun 2022)
- Website: ethicann-pharma.com
- Phone: 410-832-2040
Social Profiles
Canonical: https://fsome.com/organization/ethicann-pharmaceuticals-8247979 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.